[HTML][HTML] Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - Cell Discovery, 2022 - nature.com
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

[PDF][PDF] Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - 2022 - scienovate.com
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

[PDF][PDF] Selective Regulation of Tuft Cell-Like Small Cell Lung Cancer by Novel Transcriptional Co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - scholar.archive.org
The DepMap project has generated a huge resource for investigating selectively essential
genes, which represent potential cancer therapeutic targets. However, manually sorting out …

Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - Cell Discovery, 2022 - search.proquest.com
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

[HTML][HTML] Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - Cell Discovery, 2022 - ncbi.nlm.nih.gov
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

[引用][C] Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators
C11orf53 and COLCA2 Selective regulation of tuft cell-like small cell lung cancer by novel …

Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2.

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - Cell Discovery, 2022 - europepmc.org
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

Selective Regulation of Tuft Cell-Like Small Cell Lung Cancer by Novel Transcriptional Co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - bioRxiv, 2022 - biorxiv.org
The DepMap project has generated a huge resource for investigating selectively essential
genes, which represent potential cancer therapeutic targets. However, manually sorting out …

Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2

C Zhou, H Huang, Y Wang, E Sendinc, Y Shi - Cell Discovery, 2022 - ora.ox.ac.uk
Dear Editor, An ideal cancer therapy drug should kill cancer cells while displaying limited
toxicities toward normal cells 1. Therefore, genes essential in cancer but not normal cells are …

Selective regulation of tuft cell-like small cell lung cancer by novel transcriptional co-activators C11orf53 and COLCA2.

C Zhou, H Huang, Y Wang, E Sendinc… - Cell Discovery, 2022 - search.ebscohost.com
In addition, the growth defect of COLCA2 gRNA-treated NCI-H1048 cells was rescued by a
gRNA-resistant COLCA2 transgene (Fig. These authors contributed equally: Hui Huang …